Insider · CIK 0001588365

Bonvini Ezio

Reports to the SEC for 1 company · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001588365

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	MGNXMACROGENICS INC · Employee Stock Option (right to buy)M Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−8,000 sh	$2.60	−$20.8K	80,000
2026-10-06	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+8,000 sh	$2.60	+$20.8K	193,799
2026-08-17	MGNXMACROGENICS INC · Employee Stock Option (right to buy)M Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−40K sh	$2.60	−$104K	88,000
2026-08-17	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+40K sh	$2.60	+$104K	185,799
2026-02-15	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+16.7K sh	—	—	152,232
2026-02-15	MGNXMACROGENICS INCF Tax Payment	Sr VP, Research & CSO	FTax Payment	−6,433 sh	$1.71	−$11K	145,799
2026-02-15	MGNXMACROGENICS INC · Restricted Stock UnitM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−16.7K sh	—	—	0
2026-02-12	MGNXMACROGENICS INC · Restricted Stock UnitA Award	Sr VP, Research & CSO	AAward	+31.3K sh	—	—	31,250
2026-02-12	MGNXMACROGENICS INC · Employee Stock Option (right to buy)A Award	Sr VP, Research & CSO	AAward	+188K sh	—	—	187,500
2026-02-08	MGNXMACROGENICS INCF Tax Payment	Sr VP, Research & CSO	FTax Payment	−4,311 sh	$1.81	−$7,802.91	135,567
2026-02-08	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+11.2K sh	—	—	139,878
2026-02-08	MGNXMACROGENICS INC · Restricted Stock UnitM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−11.2K sh	—	—	11,166
2026-02-07	MGNXMACROGENICS INC · Restricted Stock UnitM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−7,001 sh	—	—	13,999
2026-02-07	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+7,001 sh	—	—	131,415
2026-02-07	MGNXMACROGENICS INCF Tax Payment	Sr VP, Research & CSO	FTax Payment	−2,703 sh	$1.81	−$4,892.43	128,712
2025-02-15	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+16.7K sh	—	—	124,414
2025-02-15	MGNXMACROGENICS INC · Restricted Stock UnitM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−16.7K sh	—	—	16,665
2025-02-08	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+11.2K sh	—	—	112,060
2025-02-08	MGNXMACROGENICS INC · Restricted Stock UnitM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−11.2K sh	—	—	22,332
2025-02-08	MGNXMACROGENICS INCF Tax Payment	Sr VP, Research & CSO	FTax Payment	−4,311 sh	$2.60	−$11.2K	107,749
2025-02-07	MGNXMACROGENICS INC · Employee Stock Option (right to buy)A Award	Sr VP, Research & CSO	AAward	+128K sh	—	—	128,000
2025-02-07	MGNXMACROGENICS INC · Restricted Stock UnitA Award	Sr VP, Research & CSO	AAward	+21K sh	—	—	21,000
2024-02-22	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+28.1K sh	—	—	110,258
2024-02-22	MGNXMACROGENICS INCF Tax Payment	Sr VP, Research & CSO	FTax Payment	−9,366 sh	$17.11	−$160K	100,892
2024-02-22	MGNXMACROGENICS INC · Restricted Stock UnitM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−28.1K sh	—	—	0
2024-02-15	MGNXMACROGENICS INC · Restricted Stock UnitM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−16.7K sh	—	—	33,330
2024-02-15	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+16.7K sh	—	—	88,004
2024-02-15	MGNXMACROGENICS INCF Tax Payment	Sr VP, Research & CSO	FTax Payment	−5,871 sh	$17.40	−$102K	82,133
2024-02-08	MGNXMACROGENICS INC · Restricted Stock UnitA Award	Sr VP, Research & CSO	AAward	+33.5K sh	—	—	33,500
2024-02-08	MGNXMACROGENICS INC · Employee Stock Option (right to buy)A Award	Sr VP, Research & CSO	AAward	+90K sh	—	—	90,000
2024-02-07	MGNXMACROGENICS INCS Sale	Sr VP, Research & CSO	SSale	−3,334 sh	$18.00	−$60K	71,334
2024-02-01	MGNXMACROGENICS INCS Sale	Sr VP, Research & CSO	SSale	−13.3K sh	$15.00	−$200K	74,668
2024-01-19	MGNXMACROGENICS INCS Sale	Sr VP, Research & CSO	SSale	−13.3K sh	$12.00	−$160K	87,984
2023-12-20	MGNXMACROGENICS INCS Sale	Sr VP, Research & CSO	SSale	−18.9K sh	$10.08	−$190K	101,300
2023-02-22	MGNXMACROGENICS INCF Tax Payment	Sr VP, Research & CSO	FTax Payment	−3,619 sh	$6.55	−$23.7K	120,180
2023-02-22	MGNXMACROGENICS INC · Restricted Stock UnitM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−9,375 sh	—	—	0
2023-02-22	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+9,375 sh	—	—	123,799
2023-02-15	MGNXMACROGENICS INC · Restricted Stock UnitA Award	Sr VP, Research & CSO	AAward	+50K sh	—	—	50,000
2023-02-15	MGNXMACROGENICS INC · Employee stock option (right to buy)A Award	Sr VP, Research & CSO	AAward	+200K sh	—	—	200,000
2022-05-14	MGNXMACROGENICS INCF Tax Payment	Sr VP, Research & CSO	FTax Payment	−1,666 sh	$4.16	−$6,930.56	114,424
2022-05-14	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+5,000 sh	—	—	116,090
2022-05-14	MGNXMACROGENICS INC · Restricted Stock UnitM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−5,000 sh	—	—	0
2022-02-22	MGNXMACROGENICS INC · Employee stock option (right to buy)A Award	Sr VP, Research & CSO	AAward	+75K sh	—	—	75,000
2022-02-22	MGNXMACROGENICS INC · Restricted Stock UnitA Award	Sr VP, Research & CSO	AAward	+37.5K sh	—	—	37,500
2021-11-16	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+2,540 sh	$16.00	+$40.6K	111,090
2021-11-16	MGNXMACROGENICS INC · Employee stock option (right to buy)M Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−2,540 sh	—	—	0
2021-06-24	MGNXMACROGENICS INC · Employee stock option (right to buy)M Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−21.9K sh	$16.00	−$350K	2,540
2021-06-24	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+21.9K sh	$16.00	+$350K	104,329
2021-06-24	MGNXMACROGENICS INCM Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	+4,221 sh	$20.53	+$86.7K	108,550
2021-06-24	MGNXMACROGENICS INC · Employee stock option (right to buy)M Exercise/Conversion	Sr VP, Research & CSO	MExercise/Conversion	−4,221 sh	$20.53	−$86.7K	63,279

Recent filings

Accepted (ET)
Oct 7 16:224
Bonvini Ezio0001125345-26-000063
SEC(opens sec.gov)
Aug 184
Bonvini Ezio0001588365-26-000007
SEC(opens sec.gov)
Feb 174
Bonvini Ezio0001588365-26-000005
SEC(opens sec.gov)
Feb 104
Bonvini Ezio0001588365-26-000002
SEC(opens sec.gov)
Feb 194
Bonvini Ezio0001125345-25-000037
SEC(opens sec.gov)
Feb 114
Bonvini Ezio0001125345-25-000019
SEC(opens sec.gov)

Companies

MACROGENICS INCSr VP, Research & CSOMGNX

Address

9704 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850